2O73
Structure of OHCU decarboxylase in complex with allantoin
2O73 の概要
| エントリーDOI | 10.2210/pdb2o73/pdb |
| 関連するPDBエントリー | 2O70 2O74 |
| 分子名称 | OHCU decarboxylase, 1-(2,5-DIOXO-2,5-DIHYDRO-1H-IMIDAZOL-4-YL)UREA (3 entities in total) |
| 機能のキーワード | decarboxylation, ohcu, 2-oxo-4-hydroxy-4-carboxy-5-ureidoimidazoline, hiu, 5-hydroxyisourate, lyase |
| 由来する生物種 | Danio rerio (zebrafish) |
| 細胞内の位置 | Peroxisome (Probable): A1L259 |
| タンパク質・核酸の鎖数 | 6 |
| 化学式量合計 | 119548.47 |
| 構造登録者 | Cendron, L.,Berni, R.,Folli, C.,Ramazzina, I.,Percudani, R.,Zanotti, G. (登録日: 2006-12-10, 公開日: 2007-04-10, 最終更新日: 2023-10-25) |
| 主引用文献 | Cendron, L.,Berni, R.,Folli, C.,Ramazzina, I.,Percudani, R.,Zanotti, G. The structure of 2-oxo-4-hydroxy-4-carboxy-5-ureidoimidazoline decarboxylase provides insights into the mechanism of uric acid degradation. J.Biol.Chem., 282:18182-18189, 2007 Cited by PubMed Abstract: The complete degradation of uric acid to (S)-allantoin, as recently elucidated, involves three enzymatic reactions. Inactivation by pseudogenization of the genes of the pathway occurred during hominoid evolution, resulting in a high concentration of urate in the blood and susceptibility to gout. Here, we describe the 1.8A resolution crystal structure of the homodimeric 2-oxo-4-hydroxy-4-carboxy-5-ureidoimidazoline decarboxylase, which catalyzes the last step in the urate degradation pathway, for both ligand-free enzyme and enzyme in complex with the substrate analogs (R)-allantoin and guanine. Each monomer comprises ten alpha-helices, grouped into two domains and assembled in a novel fold. The structure and the mutational analysis of the active site have allowed us to identify some residues that are essential for catalysis, among which His-67 and Glu-87 appear to play a particularly significant role. Glu-87 may facilitate the exit of the carboxylate group because of electrostatic repulsion that destabilizes the ground state of the substrate, whereas His-67 is likely to be involved in a protonation step leading to the stereoselective formation of the (S)-allantoin enantiomer as reaction product. The structural and functional characterization of 2-oxo-4-hydroxy-4-carboxy-5-ureidoimidazoline decarboxylase can provide useful information in view of the potential use of this enzyme in the enzymatic therapy of gout. PubMed: 17428786DOI: 10.1074/jbc.M701297200 主引用文献が同じPDBエントリー |
| 実験手法 | X-RAY DIFFRACTION (1.8 Å) |
構造検証レポート
検証レポート(詳細版)
をダウンロード






